This virtual session will give you a comprehensive overview on the topic of “flexibility of working place and working time” as well as “protection of health and data”. Please note that this event will be in held in German only.
Following the recent publication of the UK Hydrogen Strategy, the UK Government has now published its Net Zero Strategy. As expected, low carbon hydrogen development is central to this strategy. At the core of the strategy is an ambitious goal of fully decarbonizing UK power systems by 2035.
In our updated and expanded Guide to Issues for Trades of Non-Performing Loans across Europe and China, we have selected some of the key legal and practical issues to be aware of when conducting a no-performing loan trade in jurisdictions that are strongly anticipated to be key areas of activity.
Countries have been setting goals for net zero greenhouse gas emissions by 2050s, and intermediate objectives for cuts by the 2030s. The energy transition plays a fundamental part in achieving net zero.
In October 2021, the Medical Device Coordination Group published the Guidance on the classification of medical devices. In particular, the purpose of the Guidance is to ensure the proper application of the classification rules set forth in Annex VIII to the Medical Device Regulation (EU) 2017/745 (MDR).
As part of its post-Brexit trade policy, the UK has established its own independent trade remedies regime. Through its newly-formed Trade Remedies Authority, the UK can now investigate claims of unfair import practices from UK businesses and determine whether the UK Government should introduce trade remedy measures – including anti-dumping duties, countervailing duties and safeguard measures – onto imports into the UK.
On 28 September 2021, the European Commission launched a public consultation on the proposed revision of the current EU’s general legislation on medicines for human use referred to in Directive 2001/83/EC and Regulation 726/2004 in order to ensure a future-proof and crisis-resistant medicines regulatory system.
Please join us for upcoming webinars on important developments in the Consumer Goods & Retail industry. Please note that the webinar series will be held in German only
The National Institute of Pharmacy and Nutrition (“OGYÉI”) issued a Guidance on 20 September which contains useful information on the OGYÉI’s interpretation of the recent legislative amendments of Act XCVIII of 2006 concerning medicine promotion, events and contracts with HCPs.
The Medical Device Coordination Group (MDCG), the expert panel of the EU Member States and the EU Commission, has released on 20 October 2021 two guidance documents which provide meaningful guidance (1) for manufacturers, importers and distributors of “legacy devices” on which MDR obligations they must comply with (guidance document 2021-25), and (2) on the obligations of parallel importers regarding the repackaging and relabeling of medical devices under Article 16 MDR/IVDR (guidance document 2021-26).